Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88QU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,234
Award facts
- Contract value 100% obligated
- $15,233.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,233.71 to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 30, 2026, for the supply of KEVZARA 200 MG/1.14 ML pen injections. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside, competitive basis through the Defense Logistics Agency's pharmaceutical supply chain.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities, veterans' healthcare systems, and other federal medical institutions worldwide. AmerisourceBergen's contract portfolio with DLA demonstrates its significant role as a critical vendor for federal medical procurement, consistently delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F88QU?
SPE2DR26F88QU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F88QU worth?
The government has obligated $15,234 on SPE2DR26F88QU.
Is contract SPE2DR26F88QU an order under another contract?
Yes. SPE2DR26F88QU is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88QU competed?
The extent of competition for SPE2DR26F88QU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award